Introduction: Studies have used various epidemiological approaches to study associations between central nervous system (CNS) drug use in pregnancy and CNS outcomes in children. Studies have generally focused on clinical adverse effects, whereas variations in methodologies have not received sufficient attention.
Objective: Our objective was to review the methodological characteristics of existing studies to identify any limitations and recommend further research.